<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Springerplus</journal-id><journal-id journal-id-type="iso-abbrev">Springerplus</journal-id><journal-title-group><journal-title>SpringerPlus</journal-title></journal-title-group><issn pub-type="epub">2193-1801</issn><publisher><publisher-name>Springer International Publishing</publisher-name><publisher-loc>Cham</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27350914</article-id><article-id pub-id-type="pmc">4899395</article-id><article-id pub-id-type="publisher-id">2319</article-id><article-id pub-id-type="doi">10.1186/s40064-016-2319-x</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Oyster crude polysaccharides attenuates lipopolysaccharide-induced cytokines production and PPAR&#x003b3; expression in weanling piglets</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yin</surname><given-names>Guangwen</given-names></name><address><email>yinguangwen000@sina.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Juhui</given-names></name><address><email>hjuhui@126.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Ma</surname><given-names>Maotao</given-names></name><address><email>452650019@qq.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Suo</surname><given-names>Xun</given-names></name><address><email>suoxun@cau.edu.cn</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Huang</surname><given-names>Zhijian</given-names></name><address><phone>86-591-83845697</phone><email>hzjfacu@163.com</email><email>huangzj1999@sina.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><label/>Engineering Laboratory of Animal Pharmaceuticals and College of Animal Science, Fujian Agriculture and Forestry University, Fuzhou, 350002 Fujian Province China </aff><aff id="Aff2"><label/>National Animal Protozoa Laboratory and College of Veterinary Medicine, China Agricultural University, Beijing, 100193 China </aff></contrib-group><pub-date pub-type="epub"><day>23</day><month>5</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>23</day><month>5</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>5</volume><issue>1</issue><elocation-id>677</elocation-id><history><date date-type="received"><day>6</day><month>10</month><year>2015</year></date><date date-type="accepted"><day>10</day><month>5</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2016</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p></license></permissions><abstract id="Abs1"><p>This study evaluated whether oyster crude polysaccharides (OPS) attenuates lipopolysaccharide (LPS)-induced immune stress in weanling piglets. Thirty healthy crossbred piglets (28&#x000a0;&#x000b1;&#x000a0;1&#x000a0;days&#x000a0;old) were randomly divided into five groups (6&#x000a0;piglets/group). Blank control and LPS groups were fed with the basal diet, while low, medium and high dose of OPS groups were fed with the basal diet supplemented with 0.5, 0.8 and 1.2&#x000a0;% OPS, respectively, for 30&#x000a0;days. LPS group, as well as low, medium and high dose of OPS groups were then injected intraperitoneally with LPS (100&#x000a0;&#x003bc;g/kg body weight), whereas the blank control group was given phosphate buffered saline. The concentrations of TNF-&#x003b1;, IL-1&#x003b2; and IL-6 in plasma were detected by ELISA. The mRNA levels of PPAR&#x003b3; in liver, spleen, adrenal gland and thymus were evaluated by quantitative real-time PCR. The results showed that compared with the blank control, LPS treatment significantly increased plasma IL-1&#x003b2;, IL-6 and TNF-&#x003b1; levels, which was significantly attenuated by supplementing 0.5, 0.8 or 1.2&#x000a0;% OPS in the diet. In addition, LPS significantly induced expression of PPAR&#x003b3; mRNA in liver, spleen, adrenal gland, and thymus, which was blocked by adding OPS regardless of the doses. These results indicate that dietary supplementation of OPS was able to alleviate the immune stress induced by LPS.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Oyster polysaccharides</kwd><kwd>Immune stress</kwd><kwd>Cytokines</kwd><kwd>PPAR&#x003b3;</kwd><kwd>Piglets</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2016</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Background</title><p>Proinflammatory cytokines including interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor-&#x003b1; (TNF-&#x003b1;) promote systemic inflammation (Cagiola et al. <xref ref-type="bibr" rid="CR3">2006</xref>; Cook et al. <xref ref-type="bibr" rid="CR7">2011</xref>; Johnson <xref ref-type="bibr" rid="CR13">1997</xref>; Webel et al. <xref ref-type="bibr" rid="CR27">1997</xref>). Because of their proinflammatory activity, these cytokines may make a disease deteriorated by producing inflammation and tissue damage, leading to shock or death (Baggio et al. <xref ref-type="bibr" rid="CR1">2005</xref>; Netea et al. <xref ref-type="bibr" rid="CR21">2003</xref>). Previous studies have shown that in response to LPS challenge, the proinflammatory cytokines can be induced, reducing feed intake and growth in pigs (Johnson and von Borell <xref ref-type="bibr" rid="CR14">1994</xref>). Lipopolysaccharide (LPS), an endotoxin, is the major component of the outer membrane of Gram-negative bacteria such as <italic>Escherichia coli</italic> (<italic>E. coli</italic>). Administration of LPS in animals is a well-documented model for immune stress (Escribano et al. <xref ref-type="bibr" rid="CR9">2014</xref>). LPS exerts its effect through stimulating numerous cell types, such as macrophages, to produce pro-inflammatory cytokines, including TNF&#x003b1;, IL1&#x003b2; and IL6 (Webel et al. <xref ref-type="bibr" rid="CR28">1998</xref>; Dinarello <xref ref-type="bibr" rid="CR8">1996</xref>).</p><p>Peroxisome proliferator activated receptor gamma (PPAR&#x003b3;), a transcriptional factor, belongs to the ligand-activated nuclear receptor super family, and is expressed virtually in all kinds of cells, including macrophages, dendritic cells, T and B cells (Yang et al. <xref ref-type="bibr" rid="CR30">2008</xref>). PPAR&#x003b3; was originally found to regulate adipocyte differentiation and lipid metabolism (Liu et al. <xref ref-type="bibr" rid="CR18">2008</xref>; Monsalve et al. <xref ref-type="bibr" rid="CR19">2013</xref>; Mueller et al. <xref ref-type="bibr" rid="CR20">2003</xref>). However, accumulating evidence has implicated that PPAR&#x003b3; also plays an important role in the regulation of proinflammatory cytokine production, and contributes to the therapeutic effects on inflammatory diseases (Jacob et al. <xref ref-type="bibr" rid="CR12">2007</xref>; Kim et al. <xref ref-type="bibr" rid="CR15">2012</xref>). Activation of PPAR&#x003b3; has been shown to inhibit cytokine production by preventing activation and translocation of NF-&#x003ba;B (Li and Palinski <xref ref-type="bibr" rid="CR17">2006</xref>; Touyz and Schiffrin <xref ref-type="bibr" rid="CR24">2006</xref>).</p><p>The pacific oyster <italic>Crassostrea gigas</italic> (<italic>C. gigas</italic>) is a common aquaculture species widely consumed in many countries. The oyster is a rich source of dietary protein and other nutrients, such as carbohydrates, lipids, polyunsaturated fatty acids and minerals (Pennarun et al. <xref ref-type="bibr" rid="CR22">2003</xref>; Cheng et al. <xref ref-type="bibr" rid="CR5">2013</xref>). It has been described that the extract of <italic>C. gigas</italic> exhibits antioxidant activity (Watanabe et al. <xref ref-type="bibr" rid="CR26">2012</xref>). Recently, a phenolic antioxidant from the oyster has been identified (Watanabe et al. <xref ref-type="bibr" rid="CR26">2012</xref>; Yoshikawa et al. <xref ref-type="bibr" rid="CR31">1997</xref>). Strong evidence has demonstrated that polysaccharides derived from yeast and medicinal mushrooms possess immunomodulatory activity (Cheng et al. <xref ref-type="bibr" rid="CR5">2013</xref>). Feeding &#x003b2;-glucans can stimulate both specific and nonspecific immune responses in mice (Yun et al. <xref ref-type="bibr" rid="CR32">2003</xref>). Additionally, polysaccharides from aloe can also inhibit the inflammatory response (Strickland et al. <xref ref-type="bibr" rid="CR23">1999</xref>).</p><p>Although many studies have shown the immunomodulatory activities of polysaccharides, most of them focus on fungal polysaccharides. To date, limited evidence is available pertaining to the immunomodulatory activity of polysaccharides derived from animal origins. As the extract of <italic>C. gigas</italic> contains a considerable amount of carbohydrates (Cheng et al. <xref ref-type="bibr" rid="CR5">2013</xref>), we hypothesized that OPS may alter the immune response in weanling piglets. To test this hypothesis, here we investigated whether OPS attenuates LPS-induced cytokines production and PPAR&#x003b3; expression in weanling piglets.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Methods</title><sec id="Sec3"><title>Animals and treatments</title><p>Oyster crude polysaccharide (OPS) was provided by Addison Biological Technology (Beijing, China). Crossbred healthy piglets, weighing 9.91&#x000a0;&#x000b1;&#x000a0;1.38&#x000a0;kg and aged 28&#x000a0;&#x000b1;&#x000a0;1&#x000a0;days, were castrated and randomly divided into five groups (namely blank control, LPS control, low OPS, medium OPS, high OPS groups) with six replicates per group. The piglets in the blank control group and LPS group were only fed the basal diet (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>), whereas the animals in the OPS low, medium and high groups were fed the basal diet supplemented with 0.5, 0.8 and 1.2&#x000a0;% OPS, respectively. All groups were fed with the above diets for 30&#x000a0;days. Then the animals were weighed and intraperitoneally injected once with either phosphate buffered saline (PBS) (only for blank control group) or LPS (100&#x000a0;&#x003bc;g/kg body weight). The LPS (<italic>E. coli</italic> serotype O55:B5 phenol extract; Cat.# L-2630, Sigma-Aldrich, St. Louis, MO) was dissolved in PBS solution (Cat.# P-4417, Sigma-Aldrich) to make 0.4&#x000a0;mg/ml LPS solution. Three hours post injection, all piglets were euthanized for blood and tissue sampling. Six piglets from each treatment were sacrificed after feed deprivation for 12&#x000a0;h by injecting 4&#x000a0;% sodium pentobarbital solution (40&#x000a0;mg/kg body weight) for the collection of tissue samples on day 30 post weaning. The animal protocol was approved by the Animal Care Committee of Fujian Agriculture and Forestry University.<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Composition of experimental diets</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="2">Item</th><th align="left" colspan="2">Item</th></tr></thead><tbody><tr><td align="left" colspan="2">Ingredient, %</td><td align="left" colspan="2">Nutrient level, %</td></tr><tr><td align="left">&#x000a0;Corn</td><td align="left">49.8</td><td align="left">&#x000a0;Crude protein</td><td char="." align="char">19.52</td></tr><tr><td align="left">&#x000a0;Farina</td><td align="left">9</td><td align="left">&#x000a0;Crude fiber</td><td char="." align="char">2.82</td></tr><tr><td align="left">&#x000a0;Liquid feed oil</td><td align="left">2</td><td align="left">&#x000a0;Crude fat</td><td char="." align="char">4.72</td></tr><tr><td align="left">&#x000a0;Soybean meal</td><td align="left">21.3</td><td align="left">&#x000a0;Calcium</td><td char="." align="char">0.75</td></tr><tr><td align="left">&#x000a0;Fermented soybean meal</td><td align="left">5</td><td align="left">&#x000a0;Phosphorus</td><td char="." align="char">0.54</td></tr><tr><td align="left">&#x000a0;Fish meal</td><td align="left">3</td><td align="left">&#x000a0;Dry matter</td><td char="." align="char">87.53</td></tr><tr><td align="left">&#x000a0;Glucose</td><td align="left">2</td><td align="left">&#x000a0;Digestive energy (MJ/kg)</td><td char="." align="char">14.3</td></tr><tr><td align="left">&#x000a0;Sugar</td><td align="left">2</td><td align="left">&#x000a0;Lysine</td><td char="." align="char">1.33</td></tr><tr><td align="left">&#x000a0;Vitamin-mineral mix<sup>a</sup>
</td><td align="left">6</td><td align="left"/><td align="left"/></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>The vitamin and mineral premix provided the following (per kg of diet): vitamin A, 10,165&#x000a0;IU; vitamin D3, 1007&#x000a0;IU; vitamin E, 75&#x000a0;IU; Zn, 2133&#x000a0;mg; Fe, 296&#x000a0;mg; Mn, 45&#x000a0;mg; Cu, 134&#x000a0;mg; Co, 0.31&#x000a0;mg; and Se, 0.5&#x000a0;mg</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec4"><title>Blood sampling and preparation</title><p>Blood samples (10&#x000a0;ml per piglet) were collected from the precaval vein. Each sample was drawn into a plastic tube with liquaemin and centrifuged at 3000&#x000d7;<italic>g</italic> for 10&#x000a0;min at room temperature. The plasma obtained was stored at &#x02212;20&#x000a0;&#x000b0;C until analysis for cytokines.</p></sec><sec id="Sec5"><title>Tissue sampling and preparation</title><p>Approximately 1&#x000a0;g of liver, adrenal gland, thymus or spleen was collected immediately, frozen in liquid nitrogen, and stored at &#x02212;80&#x000a0;&#x000b0;C until the extraction of total RNA.</p></sec><sec id="Sec6"><title>Analysis of IL-1&#x003b2;, IL-6, and TNF-&#x003b1; concentrations</title><p>Concentrations of IL-1&#x003b2;, IL-6, and TNF-&#x003b1; in the plasma were measured using ELISA kits (Cusabio Biotech Co., Wuhan, China), according to the manufacturer&#x02019;s instructions. The sensitivity of all assays was 3&#x000a0;pg/ml.</p></sec><sec id="Sec7"><title>Quantitative real-time PCR</title><p>Total RNA was extracted from the samples using Trizol reagent (Invitrogen, Carlsbad, CA). The final RNA was eluted in an appropriate amount of 0.1&#x000a0;% diethyl pyrocarbonate (DEPC) treated water (Sigma-Aldrich). For each sample, the integrity of RNA extracted was confirmed in agarose gel electrophoresis by staining with ethidium bromide and visualizing under UV light. The amount of RNA extracted was determined, and its purity (OD260/OD280 ratio between 1.8 and 2.2) was verified using an ND-1000 spectrophotometer (NanoDropTechnologies, Wilmington, DE, USA). The cDNA was synthesized using random primers and a High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA). The primer pairs used for analysis of specific genes (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>) were designed with the PerlPrimer software (perlprimer.sourceforge.net). Quantitative real-time PCR was performed on the 7500 Real Time PCR System (Applied Biosystems) with a program of 50&#x000a0;&#x000b0;C for 2&#x000a0;min, 95&#x000a0;&#x000b0;C for 10&#x000a0;min and 40 cycles of 95&#x000a0;&#x000b0;C for 15&#x000a0;s, and 60&#x000a0;&#x000b0;C for 1&#x000a0;min. For each sample, template copy numbers were internally normalized with their respective input control. Relative expression was calculated as the ratio of template copy numbers of a sample relative to the naive control after normalizing to their respective isotype control &#x003b2;-actin (Huang et al. <xref ref-type="bibr" rid="CR11">2011</xref>).<table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Primers for real-time PCR</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Gene</th><th align="left">Primers</th><th align="left">Product Size (bp)</th><th align="left">Efficiency (%)</th></tr></thead><tbody><tr><td align="left" rowspan="2">
<italic>PPAR&#x003b3;</italic>
</td><td align="left">F: CTGACCAAAGCAAAGGCG</td><td char="." align="char" rowspan="2">191</td><td char="." align="char" rowspan="2">102</td></tr><tr><td align="left">R: TCCACGGAGCGAAACTGA</td></tr><tr><td align="left" rowspan="2">
<italic>&#x003b2;</italic>-<italic>actin</italic>
</td><td align="left">F: CCAGGTCATCACCATCGGC</td><td char="." align="char" rowspan="2">152</td><td char="." align="char" rowspan="2">103</td></tr><tr><td align="left">R: TGGCGTAGAGGTCCTTGCG</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec8"><title>Statistical analysis</title><p>Values were expressed as mean&#x000a0;&#x000b1;&#x000a0;SD. Data were subjected to one-way analysis of variance (ANOVA) to determine whether significant differences occurred in pig fed the different diets. If a significant difference was identified, differences among means were compared by Tukey&#x02019;s multiple range tests (P&#x000a0;&#x0003c;&#x000a0;0.05). Statistical analysis was performed using the Statistica software package (Version 6.0, Statsoft, Tulsa, OK, USA).</p></sec></sec><sec id="Sec9" sec-type="results"><title>Results</title><sec id="Sec10"><title>OPS attenuates LPS-induced cytokines production in piglets</title><p>As shown in Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>, treatment of piglets with LPS significantly elevated the plasma concentrations of IL-1&#x003b2;, IL-6 and TNF-&#x003b1; (<italic>P</italic>&#x000a0;<italic>&#x0003c;</italic>&#x000a0;0.05), compared with the blank control (PBS), suggesting that LPS did induce immune stress. Of interest, the LPS-induced immune stress was significantly attenuated by adding low (0.5&#x000a0;%), medium (0.8&#x000a0;%), or high dose of OPS (1.2&#x000a0;%) (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05). There was no significant difference between medium OPS group and low OPS group, in terms of the levels of the proinflammatory cytokines. To our surprise, 0.5 and 0.8&#x000a0;% OPS inhibited LPS-induced IL-6 and TNF-&#x003b1; more potently than 1.2&#x000a0;% OPS (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05).<table-wrap id="Tab3"><label>Table&#x000a0;3</label><caption><p>Effect of OPS on LPS-induced protein expression of IL-1&#x003b2;, IL-6 and TNF-&#x003b1; in the plasma of piglets</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Group</th><th align="left">IL-1&#x003b2;</th><th align="left">IL-6</th><th align="left">TNF-&#x003b1;</th></tr></thead><tbody><tr><td align="left">Blank control</td><td char="&#x000b1;" align="char">12.50&#x000a0;&#x000b1;&#x000a0;2.80<sup>b</sup>
</td><td char="&#x000b1;" align="char">2.14&#x000a0;&#x000b1;&#x000a0;0.06<sup>c</sup>
</td><td char="&#x000b1;" align="char">81.55&#x000a0;&#x000b1;&#x000a0;5.50<sup>c</sup>
</td></tr><tr><td align="left">LPS control</td><td char="&#x000b1;" align="char">32.62&#x000a0;&#x000b1;&#x000a0;12.53<sup>a</sup>
</td><td char="&#x000b1;" align="char">2.48&#x000a0;&#x000b1;&#x000a0;0.09<sup>a</sup>
</td><td char="&#x000b1;" align="char">166.65&#x000a0;&#x000b1;&#x000a0;20.88<sup>a</sup>
</td></tr><tr><td align="left">Low OPS</td><td char="&#x000b1;" align="char">11.68&#x000a0;&#x000b1;&#x000a0;3.27<sup>b</sup>
</td><td char="&#x000b1;" align="char">2.09&#x000a0;&#x000b1;&#x000a0;0.13<sup>c</sup>
</td><td char="&#x000b1;" align="char">77.62&#x000a0;&#x000b1;&#x000a0;7.82<sup>c</sup>
</td></tr><tr><td align="left">Medium OPS</td><td char="&#x000b1;" align="char">11.03&#x000a0;&#x000b1;&#x000a0;2.06<sup>b</sup>
</td><td char="&#x000b1;" align="char">2.02&#x000a0;&#x000b1;&#x000a0;0.07<sup>c</sup>
</td><td char="&#x000b1;" align="char">86.14&#x000a0;&#x000b1;&#x000a0;3.83<sup>c</sup>
</td></tr><tr><td align="left">High OPS</td><td char="&#x000b1;" align="char">12.14&#x000a0;&#x000b1;&#x000a0;2.55<sup>b</sup>
</td><td char="&#x000b1;" align="char">2.34&#x000a0;&#x000b1;&#x000a0;0.06<sup>b</sup>
</td><td char="&#x000b1;" align="char">107.85&#x000a0;&#x000b1;&#x000a0;6.61<sup>b</sup>
</td></tr></tbody></table><table-wrap-foot><p>Different letters in the same rank represent significant difference between the treatments (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05), while the same letter in the same rank means no significant difference between the treatments (<italic>P</italic>&#x000a0;&#x0003e;&#x000a0;0.05). The units for IL-1&#x003b2;, IL-6 and TNF-&#x003b1; in the table (pg/ml)</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec11"><title>OPS attenuates LPS-induced expression of PPAR&#x003b3; mRNA in piglets</title><p>As shown in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>, treatment of piglets with LPS significantly increased expression of PPAR&#x003b3; mRNA in liver, adrenal gland, thymus and spleen, compared with the blank control (PBS) (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05). LPS-induced PPAR&#x003b3; expression was significantly attenuated by adding low (0.5&#x000a0;%), medium (0.8&#x000a0;%), or high dose of OPS (1.2&#x000a0;%). It appeared that the effect of OPS on LPS-induced PPAR&#x003b3; expression was independent of concentrations of OPS used in the experiment.<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Effect of OPS on LPS-induced PPAR&#x003b3; mRNA expression in liver, adrenal gland, thymus, and spleen of piglets. Experiments were performed in duplicate and repeated in at least three independent experiments using tissues from 6 individual piglets. Results are expressed as mean&#x000a0;&#x000b1;&#x000a0;SEM. *<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05</p></caption><graphic xlink:href="40064_2016_2319_Fig1_HTML" id="MO1"/></fig></p></sec></sec><sec id="Sec12" sec-type="discussion"><title>Discussion</title><p>Immune stress induces production of proinflammatory cytokines in the body, which can decrease growth rate, and accelerate degradation of body protein. Therefore, immune stress can cause significant economic loss to livestock producers (Tuchscherer et al. <xref ref-type="bibr" rid="CR25">2002</xref>). Previous studies have shown that the proinflammatory cytokines TNF&#x003b1;, IL-6, and IL-1&#x003b2; are elevated in plasma in response to peripheral LPS injection in weaned pigs (Chirullo et al. <xref ref-type="bibr" rid="CR6">2015</xref>; Webel et al. <xref ref-type="bibr" rid="CR27">1997</xref>). Here we found that an intraperitoneal injection of LPS in weaned piglets increased the levels of TNF&#x003b1;, IL-6, and IL-1&#x003b2; in the plasma, which is consistent with the previous findings (Wright et al. <xref ref-type="bibr" rid="CR29">2000</xref>; Webel et al. <xref ref-type="bibr" rid="CR27">1997</xref>). Interestingly, LPS-induced elevation of IL-1&#x003b2;, IL-6 and TNF&#x003b1; levels was significantly attenuated by supplementing OPS in the diet, indicating that OPS may play an anti-inflammatory role in the immune stress caused by LPS. OPS may reduce the expression of TLR4, a receptor for LPS, on immune-related cells, then attenuate the release of proinflammatory cytokines. In the present study, we noticed that the inhibitory effect of the high dose (1.2&#x000a0;%) of OPS on LPS-induced cytokines was weaker than that of the low (0.5&#x000a0;%) or the medium dose (0.8&#x000a0;%) of OPS. Our explanation is that high dose of OPS may change the palatability of the diet, and the feed intake of pigs, leading to the reduced absorptive capacity of OPS. Further research is needed to address this question.</p><p>Recently, the anti-inflammatory properties of the nuclear hormone receptor family known as peroxisome proliferator-activated receptors (PPARs) have emerged, although they were originally found to be implicated in obesity, diabetes, and atherosclerosis. PPAR&#x003b3; can be activated by specific agonists, and then translocate to the nucleus to regulate the transcription of specific genes. Activation of PPAR&#x003b3; can protect cells from injury by its anti-inflammatory and immunomodulatory effects (Belvisi and Hele <xref ref-type="bibr" rid="CR2">2008</xref>). Growing evidence suggests that the benefits of PPAR&#x003b3; agonists may also be derived from their anti-inflammatory properties (Celinski et al. <xref ref-type="bibr" rid="CR4">2013</xref>; Hanks et al. <xref ref-type="bibr" rid="CR10">2010</xref>). To date, however, limited evidence is available pertaining to the anti-inflammatory properties of PPAR&#x003b3; in pigs. We found that LPS was able to induce the expression of PPAR&#x003b3; in many tissues of piglets. The high level of expression of PPAR&#x003b3; mRNA induced by LPS implies that PPAR&#x003b3; may regulate inflammation in pigs. The trend was in line with the concentrations of the proinflammatory cytokines in the plasma. Our result is consistent with the previous report that LPS can increase the expression of PPAR&#x003b3; in the white blood cells of pigs (Leininger et al. <xref ref-type="bibr" rid="CR16">1999</xref>). In the present study, we found that pigs fed OPS had lower expression of PPAR&#x003b3;, indicating that OPS may play an important role in negatively regulating the expression of PPAR&#x003b3; and the production of the pro-inflammatory cytokines. OPS may influence the expression of PPAR&#x003b3; and TLR4 on monocytes or macrophages, then regulate the production of proinflammatory cytokines after LPS-stimulation. Further research is needed to shed the light on the mechanisms whereby OPS reduces th expression of proinflammatory cytokines.</p></sec><sec id="Sec13" sec-type="conclusion"><title>Conclusion</title><p>In conclusion, dietary supplementation of OPS was able to alleviate the immune stress induced by LPS, and the observed effects after the administration of OPS are concentrations used in the experiment independent.</p></sec></body><back><ack><title>Authors&#x02019; contributions</title><p>GWY performed the experiments and wrote the manuscript. JHH and MMT executed the experiment and analyzed the sera and tissue samples. ZJH and XS conceived and designed the study. All authors read and approved the final manuscript.</p><sec id="FPar1"><title>Acknowledgements</title><p>We thank Dr. Shile Huang (Louisiana State University Health Sciences Center, USA) for reading the manuscript. This study was supported by Key Project of the Science and Technology Department of Fujian Province (2015N0017), Natural Science Foundation of Fujian Province (2015J01075) and the National Natural Science Foundation of China (31502058).</p></sec><sec id="FPar2"><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baggio</surname><given-names>V</given-names></name><name><surname>Ott</surname><given-names>F</given-names></name><name><surname>Fischer</surname><given-names>RW</given-names></name><name><surname>Gram</surname><given-names>H</given-names></name><name><surname>Peele</surname><given-names>J</given-names></name><name><surname>Spreng</surname><given-names>D</given-names></name><name><surname>Schmokel</surname><given-names>H</given-names></name><name><surname>Jungi</surname><given-names>TW</given-names></name></person-group><article-title>Production of antibodies to canine IL-1 beta and canine TNF to assess the role of proinflammatory cytokines</article-title><source>Vet Immunol Immunopathol</source><year>2005</year><volume>107</volume><issue>1&#x02013;2</issue><fpage>27</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/j.vetimm.2005.02.019</pub-id><pub-id pub-id-type="pmid">15982477</pub-id></element-citation></ref><ref id="CR2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belvisi</surname><given-names>MG</given-names></name><name><surname>Hele</surname><given-names>DJ</given-names></name></person-group><article-title>Peroxisome proliferator-activated receptors as novel targets in lung disease</article-title><source>Chest</source><year>2008</year><volume>134</volume><issue>1</issue><fpage>152</fpage><lpage>157</lpage><pub-id pub-id-type="pmid">18628217</pub-id></element-citation></ref><ref id="CR3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cagiola</surname><given-names>M</given-names></name><name><surname>Giulio</surname><given-names>S</given-names></name><name><surname>Miriam</surname><given-names>M</given-names></name><name><surname>Katia</surname><given-names>F</given-names></name><name><surname>Paola</surname><given-names>P</given-names></name><name><surname>Macri</surname><given-names>A</given-names></name><name><surname>Pasquali</surname><given-names>P</given-names></name></person-group><article-title>In vitro down regulation of proinflammatory cytokines induced by LPS tolerance in pig CD14<sup>+</sup> cells</article-title><source>Vet Immunol Immunopathol</source><year>2006</year><volume>112</volume><issue>3&#x02013;4</issue><fpage>316</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1016/j.vetimm.2006.04.002</pub-id><pub-id pub-id-type="pmid">16740319</pub-id></element-citation></ref><ref id="CR4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Celinski</surname><given-names>K</given-names></name><name><surname>Dworzanski</surname><given-names>T</given-names></name><name><surname>Fornal</surname><given-names>R</given-names></name><name><surname>Korolczuk</surname><given-names>A</given-names></name><name><surname>Madro</surname><given-names>A</given-names></name><name><surname>Brzozowski</surname><given-names>T</given-names></name><name><surname>Slomka</surname><given-names>M</given-names></name></person-group><article-title>Comparison of anti-inflammatory properties of peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone in prophylactic treatment of experimental colitis</article-title><source>J Physiol Pharmacol</source><year>2013</year><volume>64</volume><issue>5</issue><fpage>587</fpage><lpage>595</lpage><pub-id pub-id-type="pmid">24304573</pub-id></element-citation></ref><ref id="CR5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>JY</given-names></name><name><surname>Ng</surname><given-names>LT</given-names></name><name><surname>Lin</surname><given-names>CL</given-names></name><name><surname>Jan</surname><given-names>TR</given-names></name></person-group><article-title>Pacific oyster-derived polysaccharides enhance antigen-specific T helper (Th)1 immunity in vitro and in vivo</article-title><source>Immunopharmacol Immunotoxicol</source><year>2013</year><volume>35</volume><issue>2</issue><fpage>235</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.3109/08923973.2012.751398</pub-id><pub-id pub-id-type="pmid">23237389</pub-id></element-citation></ref><ref id="CR6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chirullo</surname><given-names>B</given-names></name><name><surname>Pesciaroli</surname><given-names>M</given-names></name><name><surname>Drumo</surname><given-names>R</given-names></name><name><surname>Ruggeri</surname><given-names>J</given-names></name><name><surname>Razzuoli</surname><given-names>E</given-names></name><name><surname>Pistoia</surname><given-names>C</given-names></name><name><surname>Petrucci</surname><given-names>P</given-names></name><name><surname>Martinelli</surname><given-names>N</given-names></name><name><surname>Cucco</surname><given-names>L</given-names></name><name><surname>Moscati</surname><given-names>L</given-names></name><name><surname>Amadori</surname><given-names>M</given-names></name><name><surname>Magistrali</surname><given-names>CF</given-names></name><name><surname>Alborali</surname><given-names>GL</given-names></name><name><surname>Pasquali</surname><given-names>P</given-names></name></person-group><article-title>Salmonella Typhimurium exploits inflammation to its own advantage in piglets</article-title><source>Front Microbiol</source><year>2015</year><volume>6</volume><fpage>985</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2015.00985</pub-id><pub-id pub-id-type="pmid">26441914</pub-id></element-citation></ref><ref id="CR7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>VL</given-names></name><name><surname>Holcombe</surname><given-names>SJ</given-names></name><name><surname>Gandy</surname><given-names>JC</given-names></name><name><surname>Corl</surname><given-names>CM</given-names></name><name><surname>Sordillo</surname><given-names>LM</given-names></name></person-group><article-title>Ethyl pyruvate decreases proinflammatory gene expression in lipopolysaccharide-stimulated equine monocytes</article-title><source>Vet Immunol Immunopathol</source><year>2011</year><volume>141</volume><issue>1&#x02013;2</issue><fpage>92</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/j.vetimm.2011.02.012</pub-id><pub-id pub-id-type="pmid">21419499</pub-id></element-citation></ref><ref id="CR8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinarello</surname><given-names>CA</given-names></name></person-group><article-title>Biologic basis for interleukin-1 in disease</article-title><source>Blood</source><year>1996</year><volume>87</volume><issue>6</issue><fpage>2095</fpage><lpage>2147</lpage><pub-id pub-id-type="pmid">8630372</pub-id></element-citation></ref><ref id="CR9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escribano</surname><given-names>D</given-names></name><name><surname>Campos</surname><given-names>PH</given-names></name><name><surname>Gutierrez</surname><given-names>AM</given-names></name><name><surname>Le Floc&#x02019;h</surname><given-names>N</given-names></name><name><surname>Ceron</surname><given-names>JJ</given-names></name><name><surname>Merlot</surname><given-names>E</given-names></name></person-group><article-title>Effect of repeated administration of lipopolysaccharide on inflammatory and stress markers in saliva of growing pigs</article-title><source>Vet J</source><year>2014</year><volume>200</volume><issue>3</issue><fpage>393</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.1016/j.tvjl.2014.04.007</pub-id><pub-id pub-id-type="pmid">24814313</pub-id></element-citation></ref><ref id="CR10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanks</surname><given-names>BC</given-names></name><name><surname>Kuroki</surname><given-names>K</given-names></name><name><surname>Stoker</surname><given-names>AM</given-names></name><name><surname>Cook</surname><given-names>JL</given-names></name></person-group><article-title>Evaluation of anti-inflammatory and chondroprotective effects of peroxisome proliferator-activated receptor gamma agonists in cartilage and synovial explants from dogs</article-title><source>Am J Vet Res</source><year>2010</year><volume>71</volume><issue>10</issue><fpage>1142</fpage><lpage>1147</lpage><pub-id pub-id-type="doi">10.2460/ajvr.71.10.1142</pub-id><pub-id pub-id-type="pmid">20919899</pub-id></element-citation></ref><ref id="CR11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Zou</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Yin</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Suo</surname><given-names>X</given-names></name></person-group><article-title>Transgenic <italic>Eimeria tenella</italic> expressing enhanced yellow fluorescent protein targeted to different cellular compartments stimulated dichotomic immune responses in chickens</article-title><source>J Immunol</source><year>2011</year><volume>187</volume><issue>7</issue><fpage>3595</fpage><lpage>3602</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1100043</pub-id><pub-id pub-id-type="pmid">21876035</pub-id></element-citation></ref><ref id="CR12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>R</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name></person-group><article-title>Mechanism of the anti-inflammatory effect of curcumin: PPAR-gamma activation</article-title><source>PPAR Res</source><year>2007</year><volume>2007</volume><fpage>89369</fpage><pub-id pub-id-type="doi">10.1155/2007/89369</pub-id><pub-id pub-id-type="pmid">18274631</pub-id></element-citation></ref><ref id="CR13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>RW</given-names></name></person-group><article-title>Inhibition of growth by pro-inflammatory cytokines: an integrated view</article-title><source>J Anim Sci</source><year>1997</year><volume>75</volume><issue>5</issue><fpage>1244</fpage><lpage>1255</lpage><pub-id pub-id-type="pmid">9159271</pub-id></element-citation></ref><ref id="CR14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>RW</given-names></name><name><surname>von Borell</surname><given-names>E</given-names></name></person-group><article-title>Lipopolysaccharide-induced sickness behavior in pigs is inhibited by pretreatment with indomethacin</article-title><source>J Anim Sci</source><year>1994</year><volume>72</volume><issue>2</issue><fpage>309</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">8157515</pub-id></element-citation></ref><ref id="CR15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JC</given-names></name><name><surname>Lee</surname><given-names>YH</given-names></name><name><surname>Yu</surname><given-names>MK</given-names></name><name><surname>Lee</surname><given-names>NH</given-names></name><name><surname>Park</surname><given-names>JD</given-names></name><name><surname>Bhattarai</surname><given-names>G</given-names></name><name><surname>Yi</surname><given-names>HK</given-names></name></person-group><article-title>Anti-inflammatory mechanism of PPARgamma on LPS-induced pulp cells: role of the ROS removal activity</article-title><source>Arch Oral Biol</source><year>2012</year><volume>57</volume><issue>4</issue><fpage>392</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1016/j.archoralbio.2011.09.009</pub-id><pub-id pub-id-type="pmid">21996491</pub-id></element-citation></ref><ref id="CR16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leininger</surname><given-names>MT</given-names></name><name><surname>Portocarrero</surname><given-names>CP</given-names></name><name><surname>Houseknecht</surname><given-names>KL</given-names></name></person-group><article-title>Peroxisome proliferator-activated receptor gamma1 expression in porcine white blood cells: dynamic regulation with acute endotoxemia</article-title><source>Biochem Biophys Res Commun</source><year>1999</year><volume>263</volume><issue>3</issue><fpage>749</fpage><lpage>753</lpage><pub-id pub-id-type="doi">10.1006/bbrc.1999.1467</pub-id><pub-id pub-id-type="pmid">10512751</pub-id></element-citation></ref><ref id="CR17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>AC</given-names></name><name><surname>Palinski</surname><given-names>W</given-names></name></person-group><article-title>Peroxisome proliferator-activated receptors: how their effects on macrophages can lead to the development of a new drug therapy against atherosclerosis</article-title><source>Annu Rev Pharmacol Toxicol</source><year>2006</year><volume>46</volume><fpage>1</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1146/annurev.pharmtox.46.120604.141247</pub-id><pub-id pub-id-type="pmid">16402897</pub-id></element-citation></ref><ref id="CR18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Hou</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Ding</surname><given-names>B</given-names></name><name><surname>Yin</surname><given-names>Y</given-names></name><name><surname>Yi</surname><given-names>G</given-names></name></person-group><article-title>Increased expression of the peroxisome proliferator-activated receptor gamma in the immune system of weaned pigs after <italic>Escherichia coli</italic> lipopolysaccharide injection</article-title><source>Vet Immunol Immunopathol</source><year>2008</year><volume>124</volume><issue>1&#x02013;2</issue><fpage>82</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.vetimm.2008.02.014</pub-id><pub-id pub-id-type="pmid">18394717</pub-id></element-citation></ref><ref id="CR19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monsalve</surname><given-names>FA</given-names></name><name><surname>Pyarasani</surname><given-names>RD</given-names></name><name><surname>Delgado-Lopez</surname><given-names>F</given-names></name><name><surname>Moore-Carrasco</surname><given-names>R</given-names></name></person-group><article-title>Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases</article-title><source>Mediat Inflamm</source><year>2013</year><volume>2013</volume><fpage>549627</fpage><pub-id pub-id-type="doi">10.1155/2013/549627</pub-id></element-citation></ref><ref id="CR20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname><given-names>C</given-names></name><name><surname>Weaver</surname><given-names>V</given-names></name><name><surname>Vanden Heuvel</surname><given-names>JP</given-names></name><name><surname>August</surname><given-names>A</given-names></name><name><surname>Cantorna</surname><given-names>MT</given-names></name></person-group><article-title>Peroxisome proliferator-activated receptor gamma ligands attenuate immunological symptoms of experimental allergic asthma</article-title><source>Arch Biochem Biophys</source><year>2003</year><volume>418</volume><issue>2</issue><fpage>186</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1016/j.abb.2003.08.006</pub-id><pub-id pub-id-type="pmid">14522590</pub-id></element-citation></ref><ref id="CR21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>van der Meer</surname><given-names>JWM</given-names></name><name><surname>van Deuren</surname><given-names>M</given-names></name><name><surname>Kullberg</surname><given-names>BJ</given-names></name></person-group><article-title>Proinflammatory cytokines and sepsis syndrome: not enough, or too much of a good thing?</article-title><source>Trends Immunol</source><year>2003</year><volume>24</volume><issue>5</issue><fpage>254</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1016/S1471-4906(03)00079-6</pub-id><pub-id pub-id-type="pmid">12738419</pub-id></element-citation></ref><ref id="CR22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pennarun</surname><given-names>AL</given-names></name><name><surname>Prost</surname><given-names>C</given-names></name><name><surname>Haure</surname><given-names>J</given-names></name><name><surname>Demaimay</surname><given-names>M</given-names></name></person-group><article-title>Comparison of two microalgal diets. 1. Influence on the biochemical and fatty acid compositions of raw oysters (<italic>Crassostrea gigas</italic>)</article-title><source>J Agric Food Chem</source><year>2003</year><volume>51</volume><issue>7</issue><fpage>2006</fpage><lpage>2010</lpage><pub-id pub-id-type="doi">10.1021/jf020548k</pub-id><pub-id pub-id-type="pmid">12643666</pub-id></element-citation></ref><ref id="CR23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strickland</surname><given-names>FM</given-names></name><name><surname>Darvill</surname><given-names>A</given-names></name><name><surname>Albersheim</surname><given-names>P</given-names></name><name><surname>Eberhard</surname><given-names>S</given-names></name><name><surname>Pauly</surname><given-names>M</given-names></name><name><surname>Pelley</surname><given-names>RP</given-names></name></person-group><article-title>Inhibition of UV-induced immune suppression and interleukin-10 production by plant oligosaccharides and polysaccharides</article-title><source>Photochem Photobiol</source><year>1999</year><volume>69</volume><issue>2</issue><fpage>141</fpage><lpage>147</lpage><pub-id pub-id-type="pmid">10048309</pub-id></element-citation></ref><ref id="CR24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Touyz</surname><given-names>RM</given-names></name><name><surname>Schiffrin</surname><given-names>EL</given-names></name></person-group><article-title>Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications</article-title><source>Vascul Pharmacol</source><year>2006</year><volume>45</volume><issue>1</issue><fpage>19</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/j.vph.2005.11.014</pub-id><pub-id pub-id-type="pmid">16782410</pub-id></element-citation></ref><ref id="CR25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuchscherer</surname><given-names>M</given-names></name><name><surname>Kanitz</surname><given-names>E</given-names></name><name><surname>Otten</surname><given-names>W</given-names></name><name><surname>Tuchscherer</surname><given-names>A</given-names></name></person-group><article-title>Effects of prenatal stress on cellular and humoral immune responses in neonatal pigs</article-title><source>Vet Immunol Immunopathol</source><year>2002</year><volume>86</volume><issue>3&#x02013;4</issue><fpage>195</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1016/S0165-2427(02)00035-1</pub-id><pub-id pub-id-type="pmid">12007885</pub-id></element-citation></ref><ref id="CR26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Fuda</surname><given-names>H</given-names></name><name><surname>Jin</surname><given-names>S</given-names></name><name><surname>Sakurai</surname><given-names>T</given-names></name><name><surname>Ohkawa</surname><given-names>F</given-names></name><name><surname>Hui</surname><given-names>SP</given-names></name><name><surname>Takeda</surname><given-names>S</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Koike</surname><given-names>T</given-names></name><name><surname>Chiba</surname><given-names>H</given-names></name></person-group><article-title>Isolation and characterization of a phenolic antioxidant from the Pacific oyster (<italic>Crassostrea gigas</italic>)</article-title><source>J Agric Food Chem</source><year>2012</year><volume>60</volume><issue>3</issue><fpage>830</fpage><lpage>835</lpage><pub-id pub-id-type="doi">10.1021/jf2038532</pub-id><pub-id pub-id-type="pmid">22224848</pub-id></element-citation></ref><ref id="CR27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Webel</surname><given-names>DM</given-names></name><name><surname>Finck</surname><given-names>BN</given-names></name><name><surname>Baker</surname><given-names>DH</given-names></name><name><surname>Johnson</surname><given-names>RW</given-names></name></person-group><article-title>Time course of increased plasma cytokines, cortisol, and urea nitrogen in pigs following intraperitoneal injection of lipopolysaccharide</article-title><source>J Anim Sci</source><year>1997</year><volume>75</volume><issue>6</issue><fpage>1514</fpage><lpage>1520</lpage><pub-id pub-id-type="pmid">9250511</pub-id></element-citation></ref><ref id="CR28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Webel</surname><given-names>DM</given-names></name><name><surname>Mahan</surname><given-names>DC</given-names></name><name><surname>Johnson</surname><given-names>RW</given-names></name><name><surname>Baker</surname><given-names>DH</given-names></name></person-group><article-title>Pretreatment of young pigs with vitamin E attenuates the elevation in plasma interleukin-6 and cortisol caused by a challenge dose of lipopolysaccharide</article-title><source>J Nutr</source><year>1998</year><volume>128</volume><issue>10</issue><fpage>1657</fpage><lpage>1660</lpage><pub-id pub-id-type="pmid">9772132</pub-id></element-citation></ref><ref id="CR29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>KJ</given-names></name><name><surname>Balaji</surname><given-names>R</given-names></name><name><surname>Hill</surname><given-names>CM</given-names></name><name><surname>Dritz</surname><given-names>SS</given-names></name><name><surname>Knoppel</surname><given-names>EL</given-names></name><name><surname>Minton</surname><given-names>JE</given-names></name></person-group><article-title>Integrated adrenal, somatotropic, and immune responses of growing pigs to treatment with lipopolysaccharide</article-title><source>J Anim Sci</source><year>2000</year><volume>78</volume><issue>7</issue><fpage>1892</fpage><lpage>1899</lpage><pub-id pub-id-type="pmid">10907832</pub-id></element-citation></ref><ref id="CR30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>XY</given-names></name><name><surname>Wang</surname><given-names>LH</given-names></name><name><surname>Farrar</surname><given-names>WL</given-names></name></person-group><article-title>A role for PPARgamma in the regulation of cytokines in immune cells and cancer</article-title><source>PPAR Res</source><year>2008</year><volume>2008</volume><fpage>961753</fpage><pub-id pub-id-type="pmid">18566687</pub-id></element-citation></ref><ref id="CR31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshikawa</surname><given-names>T</given-names></name><name><surname>Naito</surname><given-names>Y</given-names></name><name><surname>Masui</surname><given-names>K</given-names></name><name><surname>Fujii</surname><given-names>T</given-names></name><name><surname>Boku</surname><given-names>Y</given-names></name><name><surname>Nakagawa</surname><given-names>S</given-names></name><name><surname>Yoshida</surname><given-names>N</given-names></name><name><surname>Kondo</surname><given-names>M</given-names></name></person-group><article-title>Free radical-scavenging activity of <italic>Crassostera gigas</italic> extract (JCOE)</article-title><source>Biomed Pharmacother</source><year>1997</year><volume>51</volume><issue>8</issue><fpage>328</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1016/S0753-3322(97)88050-X</pub-id><pub-id pub-id-type="pmid">9436525</pub-id></element-citation></ref><ref id="CR32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yun</surname><given-names>CH</given-names></name><name><surname>Estrada</surname><given-names>A</given-names></name><name><surname>Van Kessel</surname><given-names>A</given-names></name><name><surname>Park</surname><given-names>BC</given-names></name><name><surname>Laarveld</surname><given-names>B</given-names></name></person-group><article-title>Beta-glucan, extracted from oat, enhances disease resistance against bacterial and parasitic infections</article-title><source>FEMS Immunol Med Microbiol</source><year>2003</year><volume>35</volume><issue>1</issue><fpage>67</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1016/S0928-8244(02)00460-1</pub-id><pub-id pub-id-type="pmid">12589959</pub-id></element-citation></ref></ref-list></back></article>